FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2100095814> ?p ?o ?g. }

• W2100095814 endingPage "605" @default.
• W2100095814 startingPage "599" @default.
• W2100095814 abstract "To investigate the clinical use patterns, clinical effect and safety of cyclosporine A (CSA) in juvenile idiopathic arthritis (JIA) in the setting of routine clinical care.An open-ended, phase IV post marketing surveillance study was conducted among members of the Pediatric Rheumatology Collaborative Study Group (PRCSG) and of the Paediatric Rheumatology International Trials Organisation (PRINTO) to identify patients with polyarticular course JIA who had received CSA during the course of their disease.A total of 329 patients, half of whom had systemic JIA, were collected in 21 countries. Data were collected during 1240 routine clinic visits. CSA was started at a mean of 5.8 years after disease onset and was given at a mean dose of 3.4 mg/kg/day. The drug was administered in combination with MTX in 61% and along with prednisone in 65% of the patients who were still receiving CSA. Among patients who were still receiving CSA therapy at the last reported visit, remission was documented in 9% of the patients, whereas in 61% of the patients the disease activity was rated as moderate or severe. The most frequent reason for discontinuation of CSA was insufficient therapeutic effect (61% of the patients); only 10% of the patients stopped CSA because of remission. In 17% of the patients, side effects of therapy was given as the primary reason for discontinuation.This survey suggests that CSA may have a less favourable efficacy profile than MTX and etanercept, whereas the frequency of side effects may be similar. The exact place of CSA in the treatment of JIA can only be established via controlled clinical trial." @default.
• W2100095814 created "2016-06-24" @default.
• W2100095814 creator A5000197944 @default.
• W2100095814 creator A5000303274 @default.
• W2100095814 creator A5000508127 @default.
• W2100095814 creator A5003805334 @default.
• W2100095814 creator A5004139633 @default.
• W2100095814 creator A5004271791 @default.
• W2100095814 creator A5005259641 @default.
• W2100095814 creator A5005896417 @default.
• W2100095814 creator A5013982414 @default.
• W2100095814 creator A5017232508 @default.
• W2100095814 creator A5018132971 @default.
• W2100095814 creator A5020603336 @default.
• W2100095814 creator A5022573190 @default.
• W2100095814 creator A5022610031 @default.
• W2100095814 creator A5023706408 @default.
• W2100095814 creator A5023961759 @default.
• W2100095814 creator A5024401438 @default.
• W2100095814 creator A5024827935 @default.
• W2100095814 creator A5025345646 @default.
• W2100095814 creator A5026072990 @default.
• W2100095814 creator A5026628009 @default.
• W2100095814 creator A5027612338 @default.
• W2100095814 creator A5028020433 @default.
• W2100095814 creator A5029069177 @default.
• W2100095814 creator A5029578969 @default.
• W2100095814 creator A5029874460 @default.
• W2100095814 creator A5035626824 @default.
• W2100095814 creator A5035835801 @default.
• W2100095814 creator A5037809826 @default.
• W2100095814 creator A5041679459 @default.
• W2100095814 creator A5043629698 @default.
• W2100095814 creator A5044969457 @default.
• W2100095814 creator A5046231825 @default.
• W2100095814 creator A5046398484 @default.
• W2100095814 creator A5046843135 @default.
• W2100095814 creator A5047446204 @default.
• W2100095814 creator A5050349550 @default.
• W2100095814 creator A5053040386 @default.
• W2100095814 creator A5054894364 @default.
• W2100095814 creator A5055162371 @default.
• W2100095814 creator A5055180780 @default.
• W2100095814 creator A5055322467 @default.
• W2100095814 creator A5055422607 @default.
• W2100095814 creator A5055799719 @default.
• W2100095814 creator A5056187036 @default.
• W2100095814 creator A5060857674 @default.
• W2100095814 creator A5061791403 @default.
• W2100095814 creator A5062345423 @default.
• W2100095814 creator A5062849046 @default.
• W2100095814 creator A5063503884 @default.
• W2100095814 creator A5066782781 @default.
• W2100095814 creator A5066850130 @default.
• W2100095814 creator A5068517463 @default.
• W2100095814 creator A5070769849 @default.
• W2100095814 creator A5072478264 @default.
• W2100095814 creator A5073401297 @default.
• W2100095814 creator A5075986078 @default.
• W2100095814 creator A5076321939 @default.
• W2100095814 creator A5076899763 @default.
• W2100095814 creator A5078070801 @default.
• W2100095814 creator A5079037628 @default.
• W2100095814 creator A5079231968 @default.
• W2100095814 creator A5079636331 @default.
• W2100095814 creator A5082320154 @default.
• W2100095814 creator A5085371768 @default.
• W2100095814 creator A5085599052 @default.
• W2100095814 creator A5089259012 @default.
• W2100095814 date "2006-12-22" @default.
• W2100095814 modified "2023-10-17" @default.
• W2100095814 title "Cyclosporine A in juvenile idiopathic arthritis. Results of the PRCSG/PRINTO phase IV post marketing surveillance study." @default.
• W2100095814 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17181934" @default.
• W2100095814 hasPublicationYear "2006" @default.
• W2100095814 type Work @default.
• W2100095814 sameAs 2100095814 @default.
• W2100095814 citedByCount "15" @default.
• W2100095814 countsByYear W21000958142014 @default.
• W2100095814 countsByYear W21000958142015 @default.
• W2100095814 countsByYear W21000958142019 @default.
• W2100095814 countsByYear W21000958142021 @default.
• W2100095814 countsByYear W21000958142022 @default.
• W2100095814 crossrefType "journal-article" @default.
• W2100095814 hasAuthorship W2100095814A5000197944 @default.
• W2100095814 hasAuthorship W2100095814A5000303274 @default.
• W2100095814 hasAuthorship W2100095814A5000508127 @default.
• W2100095814 hasAuthorship W2100095814A5003805334 @default.
• W2100095814 hasAuthorship W2100095814A5004139633 @default.
• W2100095814 hasAuthorship W2100095814A5004271791 @default.
• W2100095814 hasAuthorship W2100095814A5005259641 @default.
• W2100095814 hasAuthorship W2100095814A5005896417 @default.
• W2100095814 hasAuthorship W2100095814A5013982414 @default.
• W2100095814 hasAuthorship W2100095814A5017232508 @default.
• W2100095814 hasAuthorship W2100095814A5018132971 @default.
• W2100095814 hasAuthorship W2100095814A5020603336 @default.
• W2100095814 hasAuthorship W2100095814A5022573190 @default.
• W2100095814 hasAuthorship W2100095814A5022610031 @default.
• W2100095814 hasAuthorship W2100095814A5023706408 @default.

• next